The study included a total of 28 cases of urothelial carcinomas, which were analyzed
histopathologically and immunohistochemically using anti-human p16, c-erbB2 and Ki67 …

Materials and methods The study utilizes a retrospective, non-clinical approach via
immunohistochemical marking of the paraffin-embedded tumor tissues for the initial …

There is a major need for the identification of biomarkers, which are able to guide
personalized therapy for bladder cancer, in particular after resection of the primary tumor …

There is a clinical need to identify novel biomarkers to improve diagnostic accuracy for the
detection of urothelial tumors. The current study aimed to evaluate keratin 17 (K17), an …

Background The objective of this study was to investigate the clinical use of cytokeratin 20
(CK20) in urothelial cancer and in the evaluation of efficiency of therapy. Methods This study …

Background: Transitional cell carcinoma (TCC) of the bladder is the most common
malignancy of the urinary tract. Staging and grading of TCC of the bladder and its …

Backgroud: The aim of this study was to investigate the relationship between the expression
of tumor suppressor in lung cancer-1 (TSLC1) and miRNA-125b in bladder cancer (BC) …

METHODS RT-PCR was performed to detect XBP1s mRNA in urine samples from bladder
cancer patients as well as in bladder cancer-cell lines. TLR4-deficient and TLR-4 …

Background: The inflammation-immune response is thought to be closely related to cancer.
Although several studies have evaluated the potential prognostic value of inflammation …

Background The molecular biological characteristics and unique anatomical structure of
bladder cancer (BC), become cancer immune reaction mechanism and a predictor of good …